FGF21 and metabolic dysfunction-associated steatohepatitis: Another study exhibited that lack of FGF21 could worsen the metabolic disorders in NASH and provide the microenvironment, wherein inflammation, regenerating proliferation of hepatocytes and fibrosis may happen (26).